Oncolytics Biotech
ONCY
#10067
Rank
C$0.10 B
Marketcap
C$0.79
Share price
2.31%
Change (1 day)
-54.27%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of June 2026 : C$0.63 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is C$0.63 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$0.77 M-29.4%
2024-12-31C$1.09 M158.21%
2023-12-31C$0.42 M13.4%
2022-12-31C$0.37 M-43.04%
2021-12-31C$0.65 M62.85%
2020-12-31C$0.4 M-20.58%
2019-12-31C$0.5 M
2018-12-31N/A
2006-12-31C$0.14 M-0.36%
2005-12-31C$0.15 M0.33%
2004-12-31C$0.14 M-0.12%
2003-12-31C$0.15 M-0.29%
2002-12-31C$0.15 M0.26%
2001-12-31C$0.15 M0.15%
2000-12-31C$0.14 M0.33%
1999-12-31C$0.14 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
C$78.26 B 12,256,150.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$64.21 B 10,056,373.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
C$71.58 M 11,110.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
C$2.4 M 276.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$24.05 B 3,766,417.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
C$55.13 M 8,533.93%๐Ÿ‡บ๐Ÿ‡ธ USA